Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis-Reference-Cited by-同舟云学术

Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis

Published:2020-06 Issue:6 Volume:19 Page:502-512
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Scahill Rachael I,Zeun Paul,Osborne-Crowley Katherine,Johnson Eileanoir B,Gregory Sarah,Parker Christopher,Lowe Jessica,Nair Akshay,O'Callaghan Claire,Langley Christelle,Papoutsi Marina,McColgan Peter,Estevez-Fraga Carlos,Fayer Kate,Wellington Henny,Rodrigues Filipe B,Byrne Lauren M,Heselgrave Amanda,Hyare Harpreet,Sampaio Cristina,Zetterberg Henrik,Zhang Hui,Wild Edward J,Rees Geraint,Robbins Trevor W,Sahakian Barbara J,Langbehn Douglas,Tabrizi Sarah J

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference45 articles.

1. Huntingtin lowering strategies for disease modification in Huntington's disease;Tabrizi;Neuron,2019

2. Targeting huntingtin expression in patients with Huntington's disease;Tabrizi;N Engl J Med,2019

3. CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches;Langbehn;Am J Med Genet Part B Neuropsychiatr Genet,2010

4. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data;Tabrizi;Lancet Neurol,2009

5. Detection of Huntington's disease decades before diagnosis: the Predict-HD study;Paulsen;J Neurol Neurosurg Psychiatry,2008

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Speech Biomarkers in Huntington’s Disease: A Longitudinal Follow-Up Study in Premanifest Mutation Carriers;Journal of Huntington's Disease;2024-09-10

2. A 12-year polysomnographic study in Huntington’s: sleep problems predict disease onset and severity;2024-08-02

3. NfL concentration in CSF is a quantitative marker of the rate of neurodegeneration in aging and Huntington's disease: a semi-mechanistic model-based analysis;Frontiers in Neuroscience;2024-07-03

4. Neuroimaging to Facilitate Clinical Trials in Huntington’s Disease: Current Opinion from the EHDN Imaging Working Group;Journal of Huntington's Disease;2024-07-02

5. Plasma and CSF neurofilament light chain are stabilized in response to mutant huntingtin lowering in the brain of Huntington disease mice;2024-05-22